{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:35:04Z","timestamp":1792658104796,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Photochemistry and Photobiology B: Biology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jphotobiol.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T15:02:15Z","timestamp":1373468535000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition"],"prefix":"10.1016","volume":"126","author":[{"given":"Gemma A.","family":"Barron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphotobiol.2013.07.003_b0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"Ca-Cancer J. Clin."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/lsm.20369","article-title":"Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT centre","volume":"38","author":"Moseley","year":"2006","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","article-title":"Guidelines for topical photodynamic therapy: update","volume":"159","author":"Morton","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pdpdt.2009.12.001","article-title":"An overview of topical photodynamic therapy in dermatology","volume":"7","author":"Ibbotson","year":"2010","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14370","article-title":"A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett\u2019s oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin","volume":"14","author":"Fayter","year":"2010","journal-title":"Health Technol. Assess"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10103-007-0494-2","article-title":"ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial","volume":"23","author":"Eljamel","year":"2008","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0781.2012.00684.x","article-title":"Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?","volume":"28","author":"Ibbotson","year":"2012","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0781.2012.00681.x","article-title":"Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study","volume":"28","author":"Ibbotson","year":"2012","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.1996.423","article-title":"The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells","volume":"74","author":"Berg","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00432-008-0358-6","article-title":"Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma","volume":"134","author":"Pye","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1751-1097.2011.00985.x","article-title":"An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and\/or fluorescence guided resection","volume":"87","author":"Blake","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-2133.2003.05351.x","article-title":"The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy","volume":"149","author":"Choudry","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.2008.08668.x","article-title":"Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma","volume":"159","author":"Campbell","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0075","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/cbt.4.2.1440","article-title":"ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy","volume":"4","author":"Robey","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0085","doi-asserted-by":"crossref","first-page":"C2204","DOI":"10.1152\/ajpcell.00359.2006","article-title":"Breast cancer resistance protein (Bcrp1\/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX","volume":"292","author":"Jonker","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0090","first-page":"2589","article-title":"Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines","volume":"60","author":"Scheffer","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.2000.2590","article-title":"The product of the ABC half-transporter gene ABCG2 (BCRP\/MXR\/ABCP) is expressed in the plasma membrane","volume":"271","author":"Rocchi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0100","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0105","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1158\/0008-5472.CAN-08-4315","article-title":"Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines","volume":"69","author":"Solazzo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0110","doi-asserted-by":"crossref","first-page":"e50082","DOI":"10.1371\/journal.pone.0050082","article-title":"Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation","volume":"7","author":"Kobuchi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0115","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1091\/mbc.e02-11-0704","article-title":"Subcellular localization and activity of multidrug resistance proteins","volume":"14","author":"Rajagopal","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0120","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.3700127","article-title":"Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium","volume":"84","author":"Aust","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0125","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1158\/0008-5472.CAN-05-2021","article-title":"Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance","volume":"65","author":"Ifergan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0130","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10534-005-3709-7","article-title":"The ABC transporter Abcg2\/Bcrp: role in hypoxia mediated survival","volume":"18","author":"Krishnamurthy","year":"2005","journal-title":"Biometals"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0145","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","article-title":"Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance","volume":"83","author":"Natarajan","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1203","article-title":"Frequent expression of the multi-drug resistance-associated protein BCRP\/MXR\/ABCP\/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material","volume":"198","author":"Diestra","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0155","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2004-04-1566","article-title":"Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels","volume":"105","author":"Zhou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0160","first-page":"5850","article-title":"Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C","volume":"58","author":"Rabindran","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0165","first-page":"289","article-title":"Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential","volume":"25","author":"Hiraga","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11010-011-0980-5","article-title":"Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells","volume":"358","author":"Ogino","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jphotobiol.2011.08.007","article-title":"Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy","volume":"105","author":"Bebes","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0180","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s11095-006-0067-2","article-title":"ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells","volume":"23","author":"Asashima","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0185","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1158\/1078-0432.CCR-06-1599","article-title":"The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2","volume":"13","author":"Liu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1349-7006.2006.00371.x","article-title":"Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2","volume":"98","author":"Tamura","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2133\/dmpk.22.428","article-title":"In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs","volume":"22","author":"Tamura","year":"2007","journal-title":"Drug Metab. Pharmacokinet"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0200","first-page":"932","article-title":"A micromethod for free erythrocyte porphyrins: the FEP test","volume":"81","author":"Piomelli","year":"1973","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0205","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","article-title":"ACP best practice no. 165: front line tests for the investigation of suspected porphyria","volume":"54","author":"Deacon","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(84)90192-X","article-title":"Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias","volume":"139","author":"Lim","year":"1984","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0887-2333(00)00017-5","article-title":"Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity","volume":"14","author":"Traynor","year":"2000","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0781.2008.00324.x","article-title":"Photocontact allergic and phototoxic studies of chlorproethazine","volume":"24","author":"Kerr","year":"2008","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jphotobiol.2006.03.006","article-title":"Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines","volume":"84","author":"Ji","year":"2006","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0230","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/jcb.23145","article-title":"Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy","volume":"112","author":"Milla","year":"2011","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.abb.2004.09.025","article-title":"Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells","volume":"433","author":"Kriska","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10103-010-0810-0","article-title":"Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer","volume":"26","author":"Chen","year":"2011","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0245","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jphotobiol.2007.07.005","article-title":"5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines","volume":"88","author":"Sharma","year":"2007","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0250","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bpc.2003.12.008","article-title":"Characterization of the photoproducts of protoporphyrin IX bound to human serum albumin and immunoglobulin G","volume":"109","author":"Brancaleon","year":"2004","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0255","first-page":"1481","article-title":"Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture","volume":"57","author":"Gaullier","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/1011-1344(95)07249-7","article-title":"Formation of water-soluble porphyrins and protoporphyrin IX in 5-aminolevulinic-acid-incubated carcinoma cells","volume":"33","author":"Dietel","year":"1996","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1751-1097.2010.00821.x","article-title":"Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity","volume":"87","author":"Hefti","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jphotobiol.2013.07.003_b0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jphotobiol.2006.01.002","article-title":"Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters","volume":"83","author":"Di Venosa","year":"2006","journal-title":"J. Photochem. Photobiol. B"}],"container-title":["Journal of Photochemistry and Photobiology B: Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134413001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134413001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:43:42Z","timestamp":1760892222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1011134413001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":54,"alternative-id":["S1011134413001401"],"URL":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2013.07.003","relation":{},"ISSN":["1011-1344"],"issn-type":[{"value":"1011-1344","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Photochemistry and Photobiology B: Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2013.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}